J. Restaino

Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies.

Brian K. Chen, J. Restaino, Elizabeth Tippett, 2018, Cancer treatment and research.

Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.

E. Kanal, S. Belknap, D. West, 2014, The British journal of radiology.

Davids versus Goliaths: Pharma and academia threats to individual scientists and clinicians

Benjamin L. Schooley, J. Mckoy, W. Hrushesky, 2022, The Journal of Scientific Practice and Integrity.

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.

J. Armitage, P. Yarnold, K. Knopf, 2021, The oncologist.

Systematic Approach to Pharmacovigilance beyond the Limits: The Southern Network on Adverse Reactions (SONAR) Projects

C. Bennett, O. Sartor, J. Bian, 2014 .

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

Benjamin L. Schooley, Matthew A. Taylor, P. Yarnold, 2020, EClinicalMedicine.

Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions

Benjamin L. Schooley, Matthew A. Taylor, J. Armitage, 2019, PloS one.

Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network.

C. Bennett, D. Raisch, M. Baliga, 2016, The Journal of community and supportive oncology.

A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.

S. Xirasagar, C. Bennett, J. Mckoy, 2012, Journal of oncology practice.